SIGA Technologies to Ring the Nasdaq Opening Bell on Friday, September 14, 2018
September 13 2018 - 4:01PM
SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage
pharmaceutical company focused on the health security market, today
announced that that management will be ringing the Nasdaq Stock
Market Opening Bell on Friday, September 14, 2018. The ceremony
will take place between 9:15 and 9:30 a.m. ET, and will stream live
online at: https://new.livestream.com/nasdaq/live.
“To date 2018 has been a historic year for SIGA and we are
pleased to have the opportunity to recognize our multiple
achievements as we ring the Nasdaq opening bell,” said Phil Gomez,
CEO of SIGA Technologies. “We are proud of our contributions to
advancing health security and the opportunities ahead of us to
expand our business and successful government partnerships to
support and develop new health security assets that can protect
human health and create value for our shareholders.”
ABOUT SIGA TECHNOLOGIES, INC. and TPOXX®
SIGA Technologies, Inc. is a commercial-stage pharmaceutical
company focused on the health security market. Health security
comprises countermeasures for biological, chemical, radiological
and nuclear attacks (biodefense market), vaccines and therapies for
emerging infectious diseases, and health preparedness. Our lead
product is TPOXX®, also known as tecovirimat and ST-246®, an orally
administered and IV formulation antiviral drug for the treatment of
human smallpox disease caused by variola virus. TPOXX is a novel
small-molecule drug of which 2 million oral courses have been
delivered to the Strategic National Stockpile under Project
BioShield. The oral formulation of TPOXX was approved by the Food
and Drug Administration (FDA) for the treatment of smallpox on July
13, 2018. For more information about SIGA, please visit
www.siga.com.
About Smallpox1
Smallpox is a contagious, disfiguring and often deadly disease
that has affected humans for thousands of years.
Naturally-occurring smallpox was eradicated worldwide by 1980, the
result of an unprecedented global immunization campaign. Samples of
smallpox virus have been kept for research purposes. This has led
to concerns that smallpox could someday be used as a biological
warfare agent. A vaccine can prevent smallpox, but the risk of the
vaccine's side effects is too high to justify routine vaccination
for people at low risk of exposure to the smallpox virus.
FORWARD-LOOKING STATEMENTS
This press release contains certain "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995, as amended, including statements relating to the future
exercise of options by BARDA for procurement of TPOXX®. Such
forward-looking statements are subject to various known and unknown
risks and uncertainties, and SIGA cautions you that any
forward-looking information provided by or on behalf of SIGA is not
a guarantee of future performance. More detailed information about
SIGA and risk factors that may affect the realization of
forward-looking statements, including the forward-looking
statements in this press release, is set forth in SIGA's filings
with the Securities and Exchange Commission, including SIGA's
Annual Report on Form 10-K for the fiscal year ended December 31,
2017, and in other documents that SIGA has filed with the SEC. SIGA
urges investors and security holders to read those documents free
of charge at the SEC's web site at http://www.sec.gov. Interested
parties may also obtain those documents free of charge from SIGA.
Forward-looking statements are current only as of the date on which
such statements were made, and except for our ongoing obligations
under the United States of America federal securities laws, we
undertake no obligation to update publicly any forward-looking
statements whether as a result of new information, future events,
or otherwise.
Contacts:
InvestorsDavid Carey 212-867-1768dcarey@lazarpartners.com
MediaStephanie Seiler206-713-0124sseiler@lazarpartners.com
1
http://www.mayoclinic.org/diseases-conditions/smallpox/basics/definition/con-20022769
SIGA Technologies (NASDAQ:SIGA)
Historical Stock Chart
From Aug 2024 to Sep 2024
SIGA Technologies (NASDAQ:SIGA)
Historical Stock Chart
From Sep 2023 to Sep 2024